The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting

The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting

Massimiliano Salati,1,2 Francesco Caputo,1 Cinzia Baldessari,1 Pietro Carotenuto,3 Marco Messina,4 Stefania Caramaschi,5 Massimo Dominici,1 Luca Reggiani Bonetti5 1Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; 2PhD Program Clinical and Experimental Medicine, Un...

Full description

Bibliographic Details
Main Authors: Salati M, Caputo F, Baldessari C, Carotenuto P, Messina M, Caramaschi S, Dominici M, Bonetti LR
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Cancer Management and Research
Subjects:
biliary cancer
cholangiocarcinoma
intrahepatic
fgfr2
targeted therapy
precision medicine
Online Access:https://www.dovepress.com/the-evolving-role-of-fgfr2-inhibitors-in-intrahepatic-cholangiocarcino-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/the-evolving-role-of-fgfr2-inhibitors-in-intrahepatic-cholangiocarcino-peer-reviewed-fulltext-article-CMAR

Similar Items